Successful antibody behind the billion crown Life Science deal
Published 27 August 2015 Carl Borrebaeck (Photo: Kennet Ruona) An antibody that did not fulfil its purpose against the disease multiple sclerosis, MS, instead made its big break in cancer research and is now starring in southern Sweden’s largest licensing agreement in Life Science history. The “father” of the antibody is Professor Carl Borrebaeck. It is one of the windiest days in late summer, and
https://www.lunduniversity.lu.se/article/successful-antibody-behind-billion-crown-life-science-deal - 2025-05-01